At the headquarters of biotechnology company Novavax, scientists are developing what they hope could soon be another Covid-19 vaccine for the United States and the world. Data from the company's large ...

The U.S. just approved the updated non-mRNA COVID-19 vaccine made by Novavax for use and millions of doses are already being distributed across the country. “Novavax’s authorization today means people ...

The new COVID-19 vaccine rolled out across the country last month, giving people access to the most recent versions of the Moderna, Pfizer, and Novavax shots. But, given that you have options, which ...

Vaccine maker Novavax says its shot is highly effective against COVID-19 and also protects against variants. The Maryland-based company on Monday announced results from a large, late-stage study in ...

Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well — against new mutated ...

Novavax has been gearing up to launch a phase 3 trial of what may result in an important product: A combined flu and coronavirus vaccine. But the company now faces a roadblock, saying regulators put a ...

WASHINGTON (Reuters) - A new kind of influenza vaccine works against the new swine flu virus in animals, Novavax Inc reported on Tuesday. The company said it made the vaccine, which uses so-called ...

Novavax is available through an Emergency Use Authorization (EUA). An EUA helps make vaccines, drugs, or tests available quickly in the event of an emergency. The Food and Drug Administration (FDA) ...

Although Pfizer's and Moderna’s COVID-19 vaccines have been stealing the spotlight for years, some people are actively seeking out the lesser-known Novavax for their updated booster this fall.

Investors with a lot of money to spend have taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the trades showed up on publicly available ...

Investors with a lot of money to spend have taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the trades showed up on publicly available ...